Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 May;18(5):820-5.
doi: 10.1007/s10461-014-0749-4.

Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial

Affiliations
Randomized Controlled Trial

Measuring adherence by visual inspection of returned empty gel applicators in the CAPRISA 004 microbicide trial

Tanuja N Gengiah et al. AIDS Behav. 2014 May.

Abstract

In the CAPRISA 004 trial, adherence was estimated as the proportion of reported sex acts covered by two gel doses, which was assessed by counting returned empty gel applicators. The returned empty applicators were inspected visually in a standardized manner for residue on the outside of the applicator, as an indicator of vaginal insertion. Over 15 months, spanning 11,839 study visits by 838 women, a total of 59,800 returned empty applicators were inspected. By visual assessment, 77.5 % of these applicators appeared to have been inserted. To test the accuracy of the assessment we fitted a Cox model and found that the risk for HIV infection was doubled when less than half of the returned empty applicators had been assessed as not inserted in the vagina. Visual inspection enhanced both the accuracy of the adherence measurement and aided identification of mechanical problems with applicator use experienced by women in the trial.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

All authors report no conflicts of interest

References

    1. Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24(5):621–35. - PMC - PubMed
    1. Kenna LA, Labbe L, Barrett JS, Pfister M. Modeling and simulation of adherence: approaches and applications in therapeutics. AAPS J. 2005;7(2):E390–407. - PMC - PubMed
    1. IOM. Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: 2008.
    1. Amico KR. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness. Curr Opin HIV AIDS. 2012;7(6):542–8. - PubMed
    1. Williams BG, Abdool Karim SS, Gouws E, Abdool Karim Q. Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa. J Acquir Immune Defic Syndr. 2011;58:207–10. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources